Table 2.
Frequency of positive serological tests for, and confirmation of, HIV, HBsAg, HCV and syphilis infections in non-deferred (voluntary and replacement) blood donor candidates at the provincial hospital of Tete, Mozambique
| Total donors (n = 679) |
Voluntary donors (n = 348) |
Replacement donors (n = 331) |
P | |
|---|---|---|---|---|
| Demographic data | ||||
| Male | 609 (89.7%) | 310 (89.1%) | 299 (90.3%) | 0.59 |
| Age 25-65 years | 331 (48.7%) | 124 (35.6%) | 207 (62.5%) | < 0.001 |
| HIV testing | ||||
| Positive Determine HIV-1/2 rapid test | 73 (10.8%) | 31(8.9%) | 42 (12.7%) | 0.14 |
| Positive Determine HIV-1/2 and Uni-Gold HIV-1/2 rapid tests | 58 (8.5%) | 24 (6.9%) | 34 (10.3%) | 0.12 |
| HBV testing (HBsAg) | ||||
| Positive Determine HBsAg rapid test | 69 (10.2%) | 30 (8.6%) | 39 (11.8%) | 0.2 |
| Positive Healthease HBsAg rapid test | 190 (28.0%) | 97 (27.9%) | 93 (28.1%) | 1.0 |
| Positive Determine HBsAg rapid test corrected by Murex HBsAg EIA (INS) | 72 (10.6%) | 30 (8.6%) | 42 (12.7%) | 0.13 |
| HCV testing | ||||
| Positive SD Bioline HCV rapid test | 6 (0.9%) | 4 (1.1%) | 2 (0.6%) | 0.69 |
| Positive SD Bioline HCV rapid test confirmed by INNO-LIA (INS) | 0 | 0 | 0 | - |
| Syphilis testing | ||||
| Positive BD Macro-Vue RPR card test | 12 (1.8%) | 4 (1.1%) | 8 (2.4%) | 0.25 |
| Positive AraGen RPR card test | 16 (2.4%) | 5 (1.4%) | 11 (3.3 %) | 0.13 |
| Positive BD Macro-Vue RPR card tests confirmed by SERODIA TP°PA | 8 (1.2%) | 2 (0.6 %) | 6 (1.8%) | 0.17 |
| At least one confirmed transfusion-transmissible infection | 127 (18.7%) | 54 (15.2%) | 74 (22.4%) | 0.016 |
Note: EIA denotes Enzyme ImmunoAssay; LIA Line ImmunoAssay; INS "Instituto Nacional da Saúde" (Maputo); RPR: rapid plasma reagin; TP°PA Treponema pallidum particle agglutination.